Have you suffered injuries due to Benicar use? Multiple cases have been filed, including several in Ohio and New Jersey, and they all allege patients were harmed after taking the drug Benicar.
On December 18, 2014, attorneys representing a group of Ohio plaintiffs filed a motion with the Judicial Panel on Multidistrict Litigation (JPML).
The motion asks the federal court to consolidate Benicar cases filed around the country in the Northern District of Ohio, Cleveland division.
Drug makers and defendants Daiichi Sankyo and Forest Labs have not yet responded to the motion for consolidation.
Benicar is an angiotensin II receptor blocker approved in 2002 for the treatment of hypertension with other antihypertensive agents.
Benicar is known generically as olmesartan.
Azor and Tribenzor, which are other drugs that contain olmesartan, are also linked to health complications.
Benicar is alleged to cause severe intestinal sprue-like enteropathy, a condition similar to celiac disease. Additionally, some victims have reported chronic diarrhea and/or substantial weight loss.
In 2013, the US Food and Drug Administration (FDA) issued a drug safety communication indicating a need to change Benicar’s warning label to include the risk of “sprue-like enteropathy, including that the enteropathy may take months to years to develop.”
The announcement reportedly came after 23 incidents were reported to the agency’s Adverse Event Reporting System (AERS).
Patients were reported to have developed diarrhea and other symptoms.
However, the FDA has not issued a recall of Benicar or taken the drug off the market thus far.
For more information about Benicar, Azor and Tribenzor, speak to the drug injury attorneys at Zoll & Kranz.
Our defective drug law firm includes a practicing physician-attorney and all the technology, knowledge, and experience necessary to succeed in complex pharmaceutical injury litigation.
We fight for our clients and hold negligent drug manufacturers liable for injuries sustained by victims.
Zoll & Kranz – Defective Medical Drug and Device Lawyers
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
